Economy News. Corporate News JUNE 27, 2016

Size: px
Start display at page:

Download "Economy News. Corporate News JUNE 27, 2016"

Transcription

1 JUNE 27, 2016 Economy News After a year of frenetic lobbying by a clutch of foreign and local investors, the board of the National Stock Exchange (NSE), has finally approved the listing of its shares. (ET) The commerce department has sought cabinet approval to expand the Asia Pacific Trade Agreement (APTA), focusing on areas that will encourage domestic manufacturing as part of the Make in India initiative. (ET) In a strong message to tax evaders, Prime Minister Narendra Modi asked them to take advantage of the latest government scheme and come clean before September 30. (BL) The Central government is giving finishing touches to a policy for creating a land bank of surplus land available with public sector units (PSU) which can be auctioned. (BL) Housing sales fell 2.2% to 1.58 lakh units in seven major cities last fiscal, but the market is expected to improve by next March on the back of lower interest rates and fall in prices. (BS) Corporate News Suzlon Group on Saturday announced the completion and commissioning of its 4.20 MW maiden wind project for Ahmedabad Municipal Corporation. (BS) Adani Enterprises, the flagship company of the Adani Group, today said that it has raised Rs 1.5 bn through issuance of non-convertible debentures on private placement basis. (ET) TVS Electronics is expecting its Point-of-Sale (POS) business to grow better, driven by the retail sector. The company, which has earlier seen a decline in the Dot Matrix Printers, is focusing on POS products focusing customers, such as thermal printers, scanners and label printers to mitigate this impact. (BS) After pulling out of Tilaiya UMPP on a host of issues, Reliance Power is looking to secure a total of Rs 7.1 bn as bank guarantees and compensation from 18 procurers of the electricity project. (BS) National Hydroelectric Power Corporation (NHPC) is planning to set up a 600-MW solar power project at the Koyna hydel power complex in Maharashtra as part of an initiative to expand its solar portfolio. (BS) JSW Steel has received the environmental clearance for setting up an integrated steel unit and captive power plant in Jharkhand with an investment of Rs bn. (BS) Bharti Airtel and Malaysian firm Axiata have deferred the agreement for merger of their Bangladesh operations till September 26, (ET) Asian Paints Ltd is investing around Rs 40.0bn on setting up two manufacturing plants in Karnataka and Andhra Pradesh. (ET) Bajaj Finserv is likely to buy out its German partner Allianz SE's stakes in two insurance units-bajaj Allianz Life Insurance Co. Ltd and Bajaj Allianz General Insurance -in a deal estimated at as much as Rs.100.0bn. (ET) Pharma firm Nutraplus India today said its board will consider cancellation and withdrawal of the scheme of amalgamation of Vetpharma with the company. (ET) As a clarification on EU inspection of the Taloja plant, Alkem Labs has said that it does not have any issues with the three drugs highlighted in the letter, Company is considering to provide alternate studies to support authorization. Europe Contributes less than 1% to Total Sales. (BSE) Source: ET = Economic Times, BS = Business Standard, FE = Financial Express, BL = Business Line, ToI: Times of India, BSE = Bombay Stock Exchange Equity % Chg 24 Jun 16 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 26,398 (2.2) (1.0) 4.2 NIFTY Index 8,089 (2.2) (0.8) 4.8 BANKEX Index 19,911 (2.7) (0.2) 9.9 SPBSITIP Index 11,306 (2.1) (2.3) 0.1 BSETCG INDEX 14,297 (3.3) (1.5) 10.5 BSEOIL INDEX 9,382 (1.8) (0.4) 3.5 CNXMcap Index 13,289 (1.2) SPBSSIP Index 11,279 (1.5) World Indices Dow Jones 17,401 (3.4) (2.6) (0.7) Nasdaq 4,708 (4.1) (4.6) (1.4) FTSE 6,139 (3.1) (2.1) 0.5 NIKKEI 14,952 (7.9) (10.0) (10.8) HANGSENG 20,259 (2.9) (2.5) (1.4) Value traded (Rs cr) 24 Jun 16 % Chg - Day Cash BSE 3, Cash NSE 24, Derivatives 648, Net inflows (Rs cr) 23 Jun 16 % Chg MTD YTD FII 228 (816) 4,410 18,778 Mutual Fund ,065 FII open interest (Rs cr) 23 Jun 16 % Chg FII Index Futures 12,040 (15.5) FII Index Options 75,207 (1.9) FII Stock Futures 53,377 (2.7) FII Stock Options 6, Advances / Declines (BSE) 24 Jun 16 A B T Total % total Advances Declines , Unchanged Commodity % Chg 24 Jun 16 1 Day 1 Mth 3 Mths Crude (US$/BBL) 47.4 (0.5) (4.0) 20.1 Gold (US$/OZ) 1, Silver (US$/OZ) Debt / forex market 24 Jun 16 1 Day 1 Mth 3 Mths 10 yr G-Sec yield % Re/US$ Sensex Jun-15 Sep-15 Dec-15 Mar-16 Jun-16

2 SECTOR UPDATE Meeta Shetty, CFA PHARMA SECTOR UPDATE Tapering growth of the IPM (single digit for last three months) and the overhang of the unresolved compliance issues (for most of the companies) has weighed heavily on the valuations of the pharma companies. The Nifty Pharma index has corrected ~18% from its high in Apr-2015 vs. ~8% fall in Nifty from its high in Mar-2015 (as of 20th June 2016). The PEx for our coverage universe is trading lower by ~3-4x from its historical valuations. In spite of the current turbulence, we remain optimistic on the growth drivers, i.e. US generics and IPM. We stick to our confidence on companies with complex US pipeline, better visibility on revenues as well as focused managements. From our coverage universe, we continue to prefer - Sun Pharma, Alembic Pharma and Natco Pharma. Indian Pharma Market (IPM) growth has been a challenge The IPM market growth has remained a challenge for the past few months led by slower volume pick up as sell as pricing pressure and drug bans. The domestic market however, remains significant contributor to revenues for most of the Indian pharma companies at ~30%-60%. It also has been an avenue for steady cash flows in last few years. However, the WPI led price cut as well as the recent ban on fixed dose combinations will lead to restricted growth in the current fiscal. The IPM posted 7.7% growth for May-16 vs. 3.5% in Apr IPM growth trend Source: AIOCD Further break-up of the growth highlights that post negative volume growth for consecutive two months, IPM has posted nil volume growth in May The volume growth for IPM was impacted post the implementation of FDC ban in Mar The ban was imposed on 350 drugs and is set to impact Rs 38.0bn worth of drugs or ~3.8% of the IPM. Though companies are litigating the matter, it has impacted the growth of most of the companies. We expect the growth to pick up from coming months as volume growth revives. The price and new product introduction growth has been steady at ~7-8%. IPM growth split 30.0 New introductions Price increase Volume Source: AIOCD Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional Equities Research Group of Kotak Securities Limited. Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 2

3 Is US market getting tougher? After IPM, it's the US market which has been the key target market for all Indian as well as global generic companies. US markets still remain by far the largest export destination for pharmaceuticals and the sheer size gives us the confidence of steady growth over the next few years. However, in recent months the compliance issues and its escalation to warning letters, steep mid-teens price erosions and high base has led to slower growth for companies. The US revenues for most of the companies over the past 1-2 years were more led by one off opportunities. With competition catching up in these limited competition opportunities and simultaneous delays in ANDA approvals from USFDA are having a cascading effect on the companies. US pharma market Source: Kotak Securities - Private Client Research Compliance issues Company Key Plants where Inspection Time Contribution to issues are date elapsed revenues from Comments unresolved the plant Alembic Pharma None pending issues NA NA NA NA Cadila Hc Moraiya Jul months Significant Slowdown in USFDA approvals, resolution is very critical for the company Cipla Indore Jul months Significant Though this plant does not contribute significantly to revenues, going ahead it remain a growth driver. Dr Reddy Srikakulam, Nov-14-Feb months Significant Already received warning letter, Duvvada and Nalgonda company plans to invite USFDA in next few months Lupin Goa Jul months Significant Critical plant as ~30% of pending ANDAs are from this plant. Natco Pharma Kothur plant/ Mar-16 2 months Significant Only USFDA approved formulations plant, Chennai Plant very critical, recently an ANDA approval from the plant gives some respite. Sun Halol Aug months Significant Company has received a Warning Letter, company expects to invite USFDA for a re-inspection in Jun Torrent Pharma Indrad, Gujarat May month Significant Largest US revenues are from this plant Source: Company, Kotak Securities - Private Client Research Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 3

4 Challenges currently faced by Indian pharma companies in US Pricing pressure One of the major reasons for price erosion across the generic drugs sector is the wave of consolidation among generic drug makers, led by distributor concentration over the past few years. The bigger players in the market further pressured drug pricing for small peers. There are currently only four major drug distributors, following a rush of recent deals and partnerships within the space. These include McKesson, which bought Celesio for $5 billion in 2014, Cardinal Health which inked a partnership with CVS in 2013, AmerisourceBergen which made a pact with Walgreens Boots Alliance and Wal-Mart. Simultaneously, FDA has increased the pace of approving abbreviated new drug applications for generic drug manufacturers, which is also increasing competition and driving down prices. Total ANDA approvals Source: USFDA Delay in ANDA approvals led by compliance issues ANDA approval run rate Companies under coverage FY14 FY15 1QFY16 2QFY16 3QFY16 4QFY16 FY16 1QFY17* Alembic Pharma Cadila Hc Cipla Dr Reddy's Lupin Sun Torrent Pharma Not under coverage Aurobindo Pharma Wockhardt Glenmark Source: USFDA, Company Although the overall approval run rate for ANDA approvals has improved post implementation of GDUFA. Companies facing pending compliance issues like Cadila, Sun, Dr Reddy's, Wockhardt, have been facing delays in approvals. These delays in US ANDA approvals as well as pricing pressure are visible in the quarterly run rate of the companies wherein revenues have remained stagnant or have been lower except for instance of FTF/limited competition launches like for Lupin and Sun Pharma. Lupin launched gglumetza in Feb-16 whereas Sun launches ggleevec in Feb-2016, both are under FTF launches and will see generic competition only post Aug Though prima facie the revenues for both the companies have posted strong growth, the base business has been under pricing pressure as per managements. Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 4

5 US revenue run-rate - $ mn Companies under coverage 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 Alembic Pharma* Cadila Hc Cipla* Dr Reddy's Lupin Sun Torrent Pharma Not under coverage Aurobindo Pharma Glenmark *Export formulations revenues as US revenues not available One more notable trend which is visible across pharma companies is the sharp increase in R&D expense. Most of the companies have seen an increase between % increases in their R&D expenses. This, we believe, is to combat intense pricing pressure in generics seen in the past few months. Most of the companies are now getting onto the bandwagon of creating niche complex generics which should result in more sustained revenues in the US. Of our coverage companies, Alembic Pharma has seen the most marked increase at 276% in last eight quarters followed by Sun Pharma which saw its R&D expenses expand by 176% (mainly due to MK3222, its novel molecule). Going ahead too, the managements of most companies have guided for this increased run rate to continue. Though the efforts of current R&D expenses will result in revenues only post 2-3 years, this enables more visibility of sustained revenues over the longer run. Increased R&D expenses R&D expense (Rs mn)* 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 Alembic Pharma Cadila Hc Dr Reddy's Lupin Sun *R&D expense for Cipla &Torrent pharma - not available; Source: Company, Kotak Securities - Private Client Research Nifty Pharma Index Source: NSE Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 5

6 Coverage universe Company Latest Target EPS (Rs) PE (x) RoE (%) EV/EBIDTA (x) Reco Price (Rs) FY17E FY18E FY17E FY18E FY17E FY18E FY17E FY18E Alembic Pharma BUY Cadila Healthcare ACCUMULATE Cipla SELL Dr Reddy's Laboratories SELL 2, NM 23.9 NM 17.8 NM 13.4 NM Lupin REDUCE 1, Natco Pharma BUY Sun Pharmaceuticals BUY Torrent Pharmaceuticals SELL 1, Source: Kotak Securities - Private Client Research Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 6

7 Bulk deals Trade details of bulk deals Date Scrip name Name of client Buy/ Quantity Avg. Sell of shares price (Rs) 24-Jun AFEL Rajendra Singh Rawat S 55, Jun AFEL Surender Kumar B 21, Jun AFEL Janender Gandhi And Sons Huf B 21, Jun AFEL Janender Gandhi B 21, Jun AFEL Asha Gandhi B 21, Jun CITIZYN Jagdishkumar Lilabhai Bhatiya S 74, Jun KUBERJI Dharmendra. Pathak B 18, Jun KUBERJI Ulka Jayesh Modi B 19, Jun NOBPOL Varadharaja Perumal Jeya Baskar B 47, Source: BSE Gainers & Losers Nifty Gainers & Losers Price (Rs) chg (%) Index points Volume (mn) Gainers Mahindra & Mahindra 1, NA 1.4 Bajaj Auto 2, NA 0.3 Bharti Infra NA 3.2 Losers Tata Motors 449 (7.9) NA 41.0 Tata Motors (6.6) NA 7.8 Tata Steel 313 (6.4) NA 14.4 Source: Bloomberg Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 7

8 RATING SCALE Definitions of ratings BUY We expect the stock to deliver more than 12% returns over the next 9 months ACCUMULATE We expect the stock to deliver 5% - 12% returns over the next 9 months REDUCE We expect the stock to deliver 0% - 5% returns over the next 9 months SELL We expect the stock to deliver negative returns over the next 9 months NR Not Rated. Kotak Securities is not assigning any rating or price target to the stock. The report has been prepared for information purposes only. RS Rating Suspended. Kotak Securities has suspended the investment rating and price target for this stock, either because there is not a sufficient fundamental basis for determining, or there are legal, regulatory or policy constraints around publishing, an investment rating or target. The previous investment rating and price target, if any, are no longer in effect for this stock and should not be relied upon. NA Not Available or Not Applicable. The information is not available for display or is not applicable NM Not Meaningful. The information is not meaningful and is therefore excluded. NOTE Our target prices are with a 9-month perspective. Returns stated in the rating scale are our internal benchmark. Fundamental Research Team Dipen Shah IT, Banking, NBFC, Economy dipen.shah@kotak.com Sanjeev Zarbade Capital Goods, Engineering sanjeev.zarbade@kotak.com Teena Virmani Construction, Cement teena.virmani@kotak.com Arun Agarwal Auto & Auto Ancillary arun.agarwal@kotak.com Ruchir Khare Capital Goods, Engineering ruchir.khare@kotak.com Ritwik Rai FMCG, Media ritwik.rai@kotak.com Sumit Pokharna Oil and Gas sumit.pokharna@kotak.com Amit Agarwal Logistics, Paints, Transportation agarwal.amit@kotak.com Meeta Shetty, CFA Pharmaceuticals meeta.shetty@kotak.com Jatin Damania Metals & Mining jatin.damania@kotak.com Pankaj Kumar Midcap pankajr.kumar@kotak.com Nipun Gupta Information Technology nipun.gupta@kotak.com Jayesh Kumar Economy kumar.jayesh@kotak.com K. Kathirvelu Production k.kathirvelu@kotak.com Technical Research Team Shrikant Chouhan shrikant.chouhan@kotak.com Amol Athawale amol.athawale@kotak.com Derivatives Research Team Sahaj Agrawal sahaj.agrawal@kotak.com Rahul Sharma sharma.rahul@kotak.com Malay Gandhi malay.gandhi@kotak.com Prashanth Lalu prashanth.lalu@kotak.com Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 8

9 Disclosure/Disclaimer Kotak Securities Limited established in 1994, is a subsidiary of Kotak Mahindra Bank Limited. Kotak Securities is one of India's largest brokerage and distribution house. Kotak Securities Limited is a corporate trading and clearing member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited (NSE), Metropolitan Stock Exchange of India Limited (MSEI). Our businesses include stock broking, services rendered in connection with distribution of primary market issues and financial products like mutual funds and fixed deposits, depository services and Portfolio Management. Kotak Securities Limited is also a depository participant with National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). Kotak Securities Limited is also registered with Insurance Regulatory and Development Authority as Corporate Agent for Kotak Mahindra Old Mutual Life Insurance Limited and is also a Mutual Fund Advisor registered with Association of Mutual Funds in India (AMFI). We are registered as a Research Analyst under SEBI (Research Analyst) Regulations, We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in last five years. However SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise letters or levied minor penalty on KSL for certain operational deviations. We have not been debarred from doing business by any Stock Exchange / SEBI or any other authorities; nor has our certificate of registration been cancelled by SEBI at any point of time. We offer our research services to clients as well as our prospects. This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. This report is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is for the general information of clients of Kotak Securities Ltd. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. We have reviewed the report, and in so far as it includes current or historical information, it is believed to be reliable though its accuracy or completeness cannot be guaranteed. Neither Kotak Securities Limited, nor any person connected with it, accepts any liability arising from the use of this document. The recipients of this material should rely on their own investigations and take their own professional advice. Price and value of the investments referred to in this material may go up or down. Past performance is not a guide for future performance. Certain transactions -including those involving futures, options and other derivatives as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. Reports based on technical analysis centers on studying charts of a stock's price movement and trading volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals. Opinions expressed are our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional Equities Research Group of Kotak Securities Limited. We and our affiliates/associates, officers, directors, and employees, Research Analyst(including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company (ies) discussed herein or act as advisor or lender / borrower to such company (ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of Research Report or at the time of public appearance. Kotak Securities Limited (KSL) may have proprietary long/short position in the above mentioned scrip(s) and therefore may be considered as interested. The views provided herein are general in nature and does not consider risk appetite or investment objective of particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with KSL. Kotak Securities Limited is also a Portfolio Manager. Portfolio Management Team (PMS) takes its investment decisions independent of the PCG research and accordingly PMS may have positions contrary to the PCG research recommendation. Kotak Securities Limited does not provide any promise or assurance of favourable view for a particular industry or sector or business group in any manner. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and take professional advice before investing. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. No part of this material may be duplicated in any form and/or redistributed without Kotak Securities' prior written consent. Details of Associates are available on our website ie Research Analyst has served as an officer, director or employee of subject company(ies): No We or our associates may have received compensation from the subject company(ies) in the past 12 months. We or our associates may have managed or comanaged public offering of securities for the subject company(ies) in the past 12 months. We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates have not received any compensation or other benefits from the subject company(ies) or third party in connection with the research report. Our associates may have financial interest in the subject company(ies). Research Analyst or his/her relative's financial interest in the subject company(ies): No Kotak Securities Limited has financial interest in the subject company(ies): Cadila Healthcare Ltd, Cipla, DRL, Lupin, Sun Pharma, Natco Pharma - Yes Our associates may have actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her relatives has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Kotak Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Subject company(ies) may have been client during twelve months preceding the date of distribution of the research report. "A graph of daily closing prices of securities is available at and (Choose a company from the list on the browser and select the "three years" icon in the price chart)." Kotak Securities Limited. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai CIN: U99999MH1994PLC134051, Telephone No.: , Fax No.: Website: Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City Road, A K Vaidya Marg, Malad (East), Mumbai Telephone No: SEBI Registration No: NSE INB/INF/INE , BSE INB /INF , MSEI INE /INB /INF , AMFI ARN 0164, PMS INP and Research Analyst INH NSDL/CDSL: IN-DP-NSDL Our research should not be considered as an advertisement or advice, professional or otherwise. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and the like and take professional advice before investing. Investments in securities are subject to market risk; please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Derivatives are a sophisticated investment device. The investor is requested to take into consideration all the risk factors before actually trading in derivative contracts. Compliance Officer Details: Mr. Manoj Agarwal. Call: , or ks.compliance@kotak.com. In case you require any clarification or have any concern, kindly write to us at below ids: Level 1: For Trading related queries, contact our customer service at 'service.securities@kotak.com' and for demat account related queries contact us at ks.demat@kotak.com or call us on: Online Customers (by using your city STD code as a prefix) or Toll free numbers / , Offline Customers Level 2: If you do not receive a satisfactory response at Level 1 within 3 working days, you may write to us at ks.escalation@kotak.com or call us on and if you feel you are still unheard, write to our customer service HOD at ks.servicehead@kotak.com or call us on Level 3: If you still have not received a satisfactory response at Level 2 within 3 working days, you may contact our Compliance Officer (Name: Manoj Agarwal ) at ks.compliance@kotak.com or call on 91- (022) Level 4: If you have not received a satisfactory response at Level 3 within 7 working days, you may also approach CEO (Mr. Kamlesh Rao) at ceo.ks@kotak.com or call on 91- (022) Kotak Securities - Private Client Research Please see the Disclosure/Disclaimer on the last page For Private Circulation 9

IRB InvIT Fund NOT RATED INITIAL PUBLIC OFFER PRIVATE CLIENT RESEARCH 28 APRIL, 2017 IPO NOTE. Background

IRB InvIT Fund NOT RATED INITIAL PUBLIC OFFER PRIVATE CLIENT RESEARCH 28 APRIL, 2017 IPO NOTE. Background INITIAL PUBLIC OFFER PRIVATE CLIENT RESEARCH 28 APRIL, 2017 IPO NOTE Teena Virmani teena.virmani@kotak.com +91 22 6218 6432 IRB InvIT Fund Background NOT RATED IRB InvIT Fund, a registered infrastructure

More information

BAJAJ AUTO LIMITED (BAL)

BAJAJ AUTO LIMITED (BAL) RESULT UPDATE Arun Agarwal arun.agarwal@kotak.com +91 22 6218 6443 Summary table (Rs mn) FY17 FY18E FY19E Sales 217,667 252,529 291,601 Growth (%) (3.6) 16.0 15.5 EBITDA 44,224 47,827 57,416 EBITDA margin

More information

ASIAN GRANITO INDIA LTD

ASIAN GRANITO INDIA LTD RESULT UPDATE Teena Virmani teena.virmani@kotak.com +91 22 6218 6432 ASIAN GRANITO INDIA LTD PRICE: RS.519 RECOMMENDATION: BUY TARGET PRICE: RS.705 FY20E PE: 16.2X Asian Granito revenues for Q3FY18 were

More information

TATA MOTORS (TAMO) PRICE: RS.396 MORNING INSIGHT. February 6, 2018 RESULT UPDATE

TATA MOTORS (TAMO) PRICE: RS.396 MORNING INSIGHT. February 6, 2018 RESULT UPDATE RESULT UPDATE Arun Agarwal arun.agarwal@kotak.com +91 22 6218 6443 Summary table (Rs mn) FY18E FY19E FY20E Sales 2842322 3278593 3671201 Growth (%) 5.4 15.3 12.0 EBITDA 323,880 407,040 466,893 EBITDA margin

More information

MARUTI SUZUKI INDIA LTD (MSIL)

MARUTI SUZUKI INDIA LTD (MSIL) RESULT UPDATE Arun Agarwal arun.agarwal@kotak.com +91 22 6218 6443 Summary table (Rs mn) FY18E FY19E FY20E Sales 8,06,714 9,26,954 10,48,820 Growth (%) 18.6 14.9 13.1 EBITDA 1,25,406 1,44,216 1,73,628

More information

VRL LOGISTICS LTD PRICE: RS.373 MORNING INSIGHT. November 6, 2017 RESULT UPDATE

VRL LOGISTICS LTD PRICE: RS.373 MORNING INSIGHT. November 6, 2017 RESULT UPDATE RESULT UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 VRL LOGISTICS LTD PRICE: RS.373 RECOMMENDATION: BUY TARGET PRICE: RS.450 FY19E PE: 21.9X Healthy Outlook VRL reported Q2FY18 numbers,

More information

Volumes to decline in 3QFY16. Auctioning of iron ore mines

Volumes to decline in 3QFY16. Auctioning of iron ore mines COMPANY UPDATE Jatin Damania jatin.damania@kotak.com +91 22 6621 6137 JSW STEEL PRICE: RS.1,030 RECOMMENDATION: REDUCE TARGET PRICE: RS.1,080 FY17E PE: 11.1X Summary table (Rs mn) FY15 FY16E FY17E Sales

More information

MOIL LTD PRICE: RS.208 MORNING INSIGHT COMPANY UPDATE

MOIL LTD PRICE: RS.208 MORNING INSIGHT COMPANY UPDATE COMPANY UPDATE Jatin Damania jatin.damania@kotak.com +91 22 6218 6440 Summary table (Rs mn) FY18E FY19E FY20E Sales 12,490 13,379 14,737 Growth (%) 27.2 7.1 10.1 EBITDA 4,908 5,694 6,624 EBITDA margin

More information

ALLCARGO LOGISTICS LTD (ALL)

ALLCARGO LOGISTICS LTD (ALL) RESULT UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Summary table (Rs mn) FY17 FY18E FY19E Sales 55,833 61,233 66,150 Growth (%) (1.8) 9.7 8.0 EBITDA 4,650 5,451 6,020 EBITDA margin (%)

More information

ALLCARGO LOGISTICS LTD (ALL)

ALLCARGO LOGISTICS LTD (ALL) RESULT UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Summary table (Rs mn) FY18E FY19E FY20E Sales 59,740 63,150 65,110 Growth (%) 7.0 5.7 3.1 EBITDA 4,051 4,379 4,522 EBITDA margin (%) 6.8

More information

VIP INDUSTRIES LTD PRICE: RS.301 MORNING INSIGHT. November 8, 2017 RESULT UPDATE

VIP INDUSTRIES LTD PRICE: RS.301 MORNING INSIGHT. November 8, 2017 RESULT UPDATE RESULT UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 VIP INDUSTRIES LTD PRICE: RS.301 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.325 FY19E PE: 28.0X Strong performance continues VIP has

More information

CASTROL INDIA LTD (CIL)

CASTROL INDIA LTD (CIL) RESULT UPDATE Sumit Pokharna sumit.pokharna@kotak.com +91 22 6218 6438 CASTROL INDIA LTD (CIL) PRICE: RS.394 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.437 CY18E PE: 26.1X Castrol s performance is better

More information

CASTROL INDIA LTD (CIL)

CASTROL INDIA LTD (CIL) RESULT UPDATE MORNING INSIGHT Sumit Pokharna sumit.pokharna@kotak.com +91 22 6218 6438 Summary table (Rs mn) CY17E CY18E CY19E Sales 35,843 38,006 40,158 Growth (%) 6.3 6.0 5.7 EBITDA 10,656 11,390 12,096

More information

Kotak Securities Private Client Research

Kotak Securities Private Client Research COMPANY UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 VRL LOGISTICS LTD PRICE: RS.366 RECOMMENDATION: BUY TARGET PRICE: RS.450 FY19E PE: 21.6X Set to meet future needs VRL has reported a

More information

MARUTI SUZUKI INDIA LTD (MSIL)

MARUTI SUZUKI INDIA LTD (MSIL) COMPANY UPDATE Arun Agarwal arun.agarwal@kotak.com +91 22 6218 6443 Summary table (Rs mn) FY18E FY19E FY20E Sales 806,714 926,9541,048,820 Growth (%) 18.6 14.9 13.1 EBITDA 121,372 144,216 173,628 EBITDA

More information

CURRENT 11,016 25,162,950 6,381, PREVIOUS 10,939 24,323,550 5,130, % CHANGE 0.71% 3.45% 24.39% - - NIFTY PCR OI

CURRENT 11,016 25,162,950 6,381, PREVIOUS 10,939 24,323,550 5,130, % CHANGE 0.71% 3.45% 24.39% - - NIFTY PCR OI PRIVATE CLIENT RESEARCH JULY 13, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

GHCL LTD PRICE: RS. 324 MORNING INSIGHT. January 18, 2018 COMPANY UPDATE

GHCL LTD PRICE: RS. 324 MORNING INSIGHT. January 18, 2018 COMPANY UPDATE COMPANY UPDATE Jatin Damania jatin.damania@kotak.com +91 22 6218 6440 Summary table (Rs mn) FY17 FY18E FY19E Sales 28,105 30,934 32,988 Growth (%) 11.1 10.1 6.6 EBITDA 7,075 6,548 7,151 EBITDA margin (%)

More information

MAHARASHTRA SEAMLESS LTD (MSL)

MAHARASHTRA SEAMLESS LTD (MSL) RESULT UPDATE Ruchir Khare ruchir.khare@kotak.com +91 22 6218 6431 MAHARASHTRA SEAMLESS LTD (MSL) PRICE: RS.447 RECOMMENDATION: BUY TARGET PRICE: RS.560 FY19E PE: 11.5X MSL Q2FY18 PAT declined 12.5% YY

More information

PETRONET LNG LTD (PLNG)

PETRONET LNG LTD (PLNG) RESULT UPDATE Sumit Pokharna sumit.pokharna@kotak.com +91 22 6218 6438 PETRONET LNG LTD (PLNG) PRICE: RS.267 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.285 FY19E PE: 17.7X PLNG s Q2FY18 result is better

More information

BLUE DART EXPRESS (BDE)

BLUE DART EXPRESS (BDE) RESULT UPDATE Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Summary table (Rs mn) FY17 FY18E FY19E Sales 26,870 28,374 31,550 Growth (%) 5.2 5.6 11.2 EBITDA 2,704 3,285 3,865 EBITDA margin (%) 10.1

More information

SHANKARA BUILDING PRODUCTS LTD

SHANKARA BUILDING PRODUCTS LTD Company Update Stock Details Market cap (Rs mn) : 39056 52-wk Hi/Lo (Rs) : 2365 / 779 Face Value (Rs) : 10 3M Avg. daily volume : 176,779 Shares o/s (m) : 22.8 Source: Bloomberg Financial Summary Y/E Mar

More information

CURRENT 10,605 23,748,750 7,997, PREVIOUS 10,616 24,051,150 7,429, % CHANGE -0.10% -1.26% 7.65% - - NIFTY PCR OI 24.

CURRENT 10,605 23,748,750 7,997, PREVIOUS 10,616 24,051,150 7,429, % CHANGE -0.10% -1.26% 7.65% - - NIFTY PCR OI 24. PRIVATE CLIENT RESEARCH NOVEMBER 15, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

CYIENT LTD PRICE: RS.523 MORNING INSIGHT. October 13, 2017 RESULT UPDATE

CYIENT LTD PRICE: RS.523 MORNING INSIGHT. October 13, 2017 RESULT UPDATE RESULT UPDATE Nipun Gupta nipun.gupta@kotak.com +91 22 6218 6433 CYIENT LTD PRICE: RS.523 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.576 FY19E PE: 1.8X Cyients USD revenue grew by 6.6% QoQ to USD150mn

More information

DOLLAR INDUSTRIES LTD

DOLLAR INDUSTRIES LTD Result Update Stock Details Market cap (Rs mn) : 20088 52-wk Hi/Lo (Rs) : 515 / 354 Face Value (Rs) : 2 3M Avg. daily volume : 43,071 Shares o/s (m) : 57 Source: Bloomberg Financial Summary Y/E Mar (Rs

More information

Source: Company, * restated. Reported Vs Estimated performance. Source: Kotak Securities Private Client Research

Source: Company, * restated. Reported Vs Estimated performance. Source: Kotak Securities Private Client Research Result Update Stock Details Market cap (Rs mn) : 11997 52-wk Hi/Lo (Rs) : 1426 / 932 Face Value (Rs) : 10 3M Avg. daily volume : 18,854 Shares o/s (m) : 10 Source: Bloomberg Financial Summary Y/E Mar (Rs

More information

CURRENT 10,314 19,539,000 9,172, PREVIOUS 10,379 20,322,150 13,384, % CHANGE -0.62% -3.85% % - - NIFTY PCR OI

CURRENT 10,314 19,539,000 9,172, PREVIOUS 10,379 20,322,150 13,384, % CHANGE -0.62% -3.85% % - - NIFTY PCR OI PRIVATE CLIENT RESEARCH OCTOBER 10, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

Kotak Securities Private Client Research

Kotak Securities Private Client Research RESULT UPDATE Sanjeev Zarbade sanjeev.zarbade@kotak.com +91 22 6218 6424 GREAVES COTTON LTD PRICE: RS.127 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.136 FY19E PE: 16.9X Greaves Cotton (GCL) reported weak

More information

CENTRAL DEPOSITORY SERVICES (INDIA) LTD

CENTRAL DEPOSITORY SERVICES (INDIA) LTD Result Update Stock Details Market cap (Rs mn) : 28006 52-wk Hi/Lo (Rs) : 398 / 251 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 360,442 Shares o/s (m) : 105 Source: Bloomberg Financial Summary Y/E Mar

More information

CUMMINS INDIA LTD PRICE: RS.724 MORNING INSIGHT COMPANY UPDATE

CUMMINS INDIA LTD PRICE: RS.724 MORNING INSIGHT COMPANY UPDATE COMPANY UPDATE Ruchir Khare ruchir.khare@kotak.com +91 22 6218 6431 Summary table (Rs mn) FY18E FY19E FY20E Sales 50418 55090 61933 Growth (%) 1.6 9.1 12.2 EBITDA 7545 8740 10358 EBITDA margin (%) 14.6

More information

APOLLO TYRES (APTY) PRICE: RS.243 MORNING INSIGHT. November 7, 2017 RESULT UPDATE

APOLLO TYRES (APTY) PRICE: RS.243 MORNING INSIGHT. November 7, 2017 RESULT UPDATE RESULT UPDATE Arun Agarwal arun.agarwal@kotak.com +91 22 6218 6443 Summary table (Rs mn) FY17 FY18E FY19E Sales 131,800 150,121 174,715 Growth (%) 11.2 13.9 16.4 EBITDA 18,464 16,251 24,628 EBITDA margin

More information

ENGINEERS INDIA LTD (EIL)

ENGINEERS INDIA LTD (EIL) COMPANY UPDATE Ruchir Khare ruchir.khare@kotak.com +91 22 6218 6431 ENGINEERS INDIA LTD (EIL) PRICE: RS.149 RECOMMENDATION: BUY TARGET PRICE: RS.182 FY19E PE: 18.5X EIL management expects pickup in domestic

More information

CURRENT 10,615 23,795,700 1,918, PREVIOUS 10,555 23,609,550 5,351, % CHANGE 0.57% 0.79% -64.

CURRENT 10,615 23,795,700 1,918, PREVIOUS 10,555 23,609,550 5,351, % CHANGE 0.57% 0.79% -64. PRIVATE CLIENT RESEARCH NOVEMBER 9, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

Economy News. Corporate News DECEMBER 22, 2015

Economy News. Corporate News DECEMBER 22, 2015 DECEMBER 22, 2015 Economy News The government might consider pruning the list of around 300 goods exempt from excise duty in the Budget to make up for the extra expenditure on account of higher government

More information

CURRENT 10,631 23,674,650 5,909, PREVIOUS 10,605 23,748,750 7,997, % CHANGE 0.24% -0.31% % - - NIFTY PCR OI 24.

CURRENT 10,631 23,674,650 5,909, PREVIOUS 10,605 23,748,750 7,997, % CHANGE 0.24% -0.31% % - - NIFTY PCR OI 24. PRIVATE CLIENT RESEARCH NOVEMBER 16, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

MOIL LTD PRICE RS.165 TARGET RS.260 BUY. Result Update. Key Highlights. Valuation & outlook

MOIL LTD PRICE RS.165 TARGET RS.260 BUY. Result Update. Key Highlights. Valuation & outlook Result Update Stock Details Market cap (Rs mn) : 42609 52-wk Hi/Lo (Rs) : 262 / 154 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 361,552 Shares o/s (mn) : 258 Source: Bloomberg Financial Summary Y/E

More information

CURRENT 10,768 24,769,350 5,068, PREVIOUS 10,687 24,242,250 6,364, % CHANGE 0.76% 2.17% % - - NIFTY PCR OI

CURRENT 10,768 24,769,350 5,068, PREVIOUS 10,687 24,242,250 6,364, % CHANGE 0.76% 2.17% % - - NIFTY PCR OI PRIVATE CLIENT RESEARCH NOVEMBER 20, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

VASCON ENGINEERS LTD (VEL)

VASCON ENGINEERS LTD (VEL) Result Update Stock Details Market cap (Rs mn) : 4702 52-wk Hi/Lo (Rs) : 52 / 25 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 464,769 Shares o/s (mn) : 174 Source: Bloomberg Financial Summary (consolidated)

More information

TIME TECHNOPLAST LTD PRICE: RS.198 MORNING INSIGHT. October 6, 2017 COMPANY UPDATE

TIME TECHNOPLAST LTD PRICE: RS.198 MORNING INSIGHT. October 6, 2017 COMPANY UPDATE COMPANY UPDATE Sanjeev Zarbade sanjeev.zarbade@kotak.com +91 22 6218 6424 TIME TECHNOPLAST LTD PRICE: RS.198 RECOMMENDATION: ACCUMULATE TARGET PRICE: RS.216 FY19E PE: 16.6X In our meeting with the promoters

More information

MAHINDRA HOLIDAYS & RESORTS INDIA LTD

MAHINDRA HOLIDAYS & RESORTS INDIA LTD Company Visit Note Stock Details Market cap (Rs mn) : 41728 52-wk Hi/Lo (Rs) : 490 / 271 Face Value (Rs) : 10 3M Avg. daily volume : 193,423 Shares o/s (m) : 133 Source: Bloomberg Financial Summary Y/E

More information

Valuation & outlook. Quarterly performance table. Source: Company, Kotak Securities Private Client Research

Valuation & outlook. Quarterly performance table. Source: Company, Kotak Securities Private Client Research GHCL LTD PRICE RS.253 TARGET RS.330 BUY Financial Summary Y/E Mar (Rs mn) FY18 FY19E FY20E Revenue 29,432 32,724 35,579 Growth (%) 4.7 11.2 8.7 EBITDA 6,061 6,928 7,548 EBITDA margin (%) 20.6 21.2 21.2

More information

CURRENT 10,978 21,026,025 6,580, PREVIOUS 10,987 21,244,425 4,721, % CHANGE -0.08% -1.03% 39.38% - - NIFTY PCR OI

CURRENT 10,978 21,026,025 6,580, PREVIOUS 10,987 21,244,425 4,721, % CHANGE -0.08% -1.03% 39.38% - - NIFTY PCR OI PRIVATE CLIENT RESEARCH DECEMBER 21, 2018 Sahaj Agrawal Malay Gandhi Prashanth Lalu Prasenjit Biswas, CMT, CFTe sahaj.agrawal@kotak.com malay.gandhi@kotak.com prashanth.lalu@kotak.com prasenjit.biswas@kotak.com

More information

Valuation and Outlook. Source: Kotak Securities Private Client Research

Valuation and Outlook. Source: Kotak Securities Private Client Research Result Update Stock Details Market cap (Rs mn) : 31706 52-wk Hi/Lo (Rs) : 233 / 116 Face Value (Rs) : 1 3M Avg. daily vol (Nos) : 314,967 Shares o/s (mn) : 226 Source: Bloomberg Financial Summary Y/E Mar

More information

NIIT LTD PRICE RS.72 TARGET RS.110 BUY. Result Update. Key Highlights

NIIT LTD PRICE RS.72 TARGET RS.110 BUY. Result Update. Key Highlights Result Update Stock Details Market cap (Rs mn) : 11918 52-wk Hi/Lo (Rs) : 125 / 61 Face Value (Rs) : 2 3M Avg. daily vol (Nos) : 1,267,868 Shares o/s (mn) : 167 Source: Bloomberg Financial Summary Y/E

More information

CENTRAL DEPOSITORY SERVICES (INDIA) LTD

CENTRAL DEPOSITORY SERVICES (INDIA) LTD Company Update Stock Details Market cap (Rs mn) : 24045 52-wk Hi/Lo (Rs) : 382 / 205 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 276,041 Shares o/s (m) : 105 Source: Bloomberg Financial Summary Y/E

More information

KNR CONSTRUCTIONS LTD

KNR CONSTRUCTIONS LTD Company Visit Note Stock Details Market cap (Rs mn) : 45560 52-wk Hi/Lo (Rs) : 349 / 185 Face Value (Rs) : 2 3M Avg. daily volume (mn) : 268,895 Shares o/s (m) : 141 Source: Bloomberg Financial Summary

More information

COCHIN SHIPYARD LTD (COSH)

COCHIN SHIPYARD LTD (COSH) Company Update Stock Details Market cap (Rs mn) : 54340 52-wk Hi/Lo (Rs) : 599 / 356 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 120,885 Shares o/s (mn) : 136 Source:Bloomberg Financial Summary Y/E

More information

DILIP BUILDCON LTD (DBL)

DILIP BUILDCON LTD (DBL) COMPANY UPDATE Teena Virmani teena.virmani@kotak.com +91 22 6218 6432 Summary table (Rs mn) FY18E FY19E FY20E Sales 70,347 84,417 97,079 Growth (%) 38.0 20.0 15.0 EBITDA 12,655 15,608 17,949 EBITDA margin

More information

MOLD-TEK PACKAGING LIMITED (MTPL)

MOLD-TEK PACKAGING LIMITED (MTPL) Result Update Stock Details Market cap (Rs mn) : 8501 52-wk Hi/Lo (Rs) : 374 / 254 Face Value (Rs) : 5 3M Avg. daily vol (Nos) : 40,010 Shares o/s (mn) : 27.7 Source: Bloomberg Financial Summary Y/E Mar

More information

Initial Public Offer TCNS CLOTHING CO LTD NOT RATED. Company Background. IPO Note JULY 12, 2018

Initial Public Offer TCNS CLOTHING CO LTD NOT RATED. Company Background. IPO Note JULY 12, 2018 Initial Public Offer IPO Note TCNS CLOTHING CO LTD Company Background NOT RATED TCNS Clothing Co Ltd (TCCL) is India s leading women s branded apparel company in terms of total number of exclusive brand

More information

MAHARASHTRA SEAMLESS LIMITED (MSL)

MAHARASHTRA SEAMLESS LIMITED (MSL) Result Update Stock Details Market cap (Rs mn) : 29121 52-wk Hi/Lo (Rs) : 552 / 333 Face Value (Rs) : 5 3M Avg. daily volume (mn) : 71,033 Shares o/s (m) : 67 Source: Bloomberg Financial Summary Y/E Mar

More information

Auto Invest SIP in Stocks

Auto Invest SIP in Stocks Auto Invest SIP in Stocks Webinar Presentation By Rusmik Oza Sr.VP (Head of Fundamental Research) 24 th October 2018 Maruti Suzuki India Ltd. September 2018 3 Year 35% 10Year 33% 5 Year 39% Why to start

More information

NMDC LTD PRICE RS.108 TARGET RS.125 BUY. Company Update. Key Highlights. Outlook. Key Risks

NMDC LTD PRICE RS.108 TARGET RS.125 BUY. Company Update. Key Highlights. Outlook. Key Risks Company Update Stock Details Market cap (Rs mn) : 3435 52-wk Hi/Lo (Rs) : 13 / 4 Face Value (Rs) : 1 3M Avg. daily vol (Nos) : 3,14,50 Shares o/s (mn) : 314 Source: Bloomberg Financial Summary Y/E Mar

More information

GENUS POWER INFRASTRUCTURE LTD

GENUS POWER INFRASTRUCTURE LTD Result Update Stock Details Market cap (Rs mn) : 7115 52-wk Hi/Lo (Rs) : 86 / 23 Face Value (Rs) : 1 3M Avg. daily vol (Nos) : 332,091 Shares o/s (mn) : 257.3 Source:Bloomberg Financial Summary Y/E Mar

More information

News Highlights. What s Inside

News Highlights. What s Inside Morning Insight SEPTEMBER 5, 2018 % Chg 4-Sep 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 38,158 (0.4) 1.6 9.0 NIFTY Index 11,520 (0.5) 1.4 8.4 NSEBANK Index 27,431 (1.4) (1.0) 4.5 NIFTY 500 Index 9,806

More information

CYIENT LTD PRICE RS.613 TARGET RS.719 BUY. Result Update. Key Highlights

CYIENT LTD PRICE RS.613 TARGET RS.719 BUY. Result Update. Key Highlights Result Update Stock Details Market cap (Rs mn) : 69179 52-wk Hi/Lo (Rs) : 887 / 575 Face Value (Rs) : 5 3M Avg. daily vol (Nos) : 213,754 Shares o/s (mn) : 113 Source: Bloomberg Financial Summary Y/E Mar

More information

COCHIN SHIPYARD LTD (COSH)

COCHIN SHIPYARD LTD (COSH) IPO NOTE COCHIN SHIPYARD LTD (COSH) PRIVATE CLIENT RESEARCH JULY 27, 2017 Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Details of the issue Price Band Rs 424 to Rs 432 No of shares 33,984,000 Allocation

More information

STOCK RECOMMENDATIONS

STOCK RECOMMENDATIONS STOCK RECOMMENDATIONS PRIVATE CLIENT RESEARCH FEBRUARY 1, 2017 Agri-Products Insecticides (India) Ltd BUY 569 498 582 2.2 06-Jan-17 11,762 28.2 38.8 20.2 14.7 13.4 16.2 12.0 9.4 Finolex Industries BUY

More information

BERGER PAINTS LTD (BERGER)

BERGER PAINTS LTD (BERGER) Management Meet Update Stock Details Market cap (Rs mn) : 327336 52-wk Hi/Lo (Rs) : 350 / 232 Face Value (Rs) : 1 3M Avg. daily vol (Nos) : 992,827 Shares o/s (mn) : 971.0 Financial Summary Y/E Mar (Rs

More information

Presentation on Equity Markets. 15 th Jun 18

Presentation on Equity Markets. 15 th Jun 18 Presentation on Equity Markets 15 th Jun 18 Four Pillars of Indian Equity Market Macros Flows Earnings Valuations Broader Macros: Could weaken (due to crude & twin deficits) Source: Kotak Institutional

More information

Securities Lending & Borrowing Mechanism (SLBM)

Securities Lending & Borrowing Mechanism (SLBM) Securities Lending & Borrowing Mechanism (SLBM) Are you.. Looking for opportunities to earn from your long term Equity investments? Need a low risk option? Which also secures your precious holdings? SLBM

More information

QUESS CORP LTD (QUESS)

QUESS CORP LTD (QUESS) Result Update Stock Details Market cap (Rs mn) : 164121 52-wk Hi/Lo (Rs) : 1303 / 784 Face Value (Rs) : 10 3M Avg. daily volume : 109,893 Shares o/s (m) : 145 Source: Bloomberg Financial Summary Y/E Mar

More information

GENUS POWER INFRASTRUCTURE LTD

GENUS POWER INFRASTRUCTURE LTD COMPANY VISIT NOTE Sanjeev Zarbade sanjeev.zarbade@kotak.com +91 22 6218 6424 Summary table (Rs mn) FY18E FY19E FY20E Sales 8043 10247 12416 Growth % 25.2 27.4 21.2 EBITDA 859 1230 1618 EBITDA margin %

More information

Valuation & outlook. Quarterly performance table

Valuation & outlook. Quarterly performance table Stock Details Result Update Market cap (Rs mn) : 47224 52-wk Hi/Lo (Rs) : 500 / 195 Face Value (Rs) : 2 3M Avg. daily vol (Nos) : 617,776 Shares o/s (mn) : 133 Source:Bloomberg Financial Summary Y/E Mar

More information

ADANI PORT AND SEZ (APSEZ)

ADANI PORT AND SEZ (APSEZ) Company Update Stock Details Market cap (Rs mn) : 781681 52-wk Hi/Lo (Rs) : 452 / 347 Face Value (Rs) : 2 3M Avg. daily vol (Nos) : 4,176,088 Shares o/s (mn) : 2071 Source: Bloomberg Financial Summary

More information

News Highlights. What s Inside. Company Update Allcargo Logistics Limited

News Highlights. What s Inside. Company Update Allcargo Logistics Limited Morning Insight DECEMBER 7, 2018 % Chg 6-Dec 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 35,312 (1.6) 0.9 (7.7) NIFTY Index 10,601 (1.7) 0.7 (8.1) NSEBANK Index 26,198 (1.2) 2.3 (4.6) NIFTY 500 Index

More information

ARVIND LTD PRICE RS.101 TARGET RS.130 BUY. Company Update. Outlook & Valuation. Demerger to increase focus on each business separately

ARVIND LTD PRICE RS.101 TARGET RS.130 BUY. Company Update. Outlook & Valuation. Demerger to increase focus on each business separately Company Update Stock Details Market cap (Rs mn) : 26056 52-wk Hi/Lo (Rs) : 169 / 90 Face Value (Rs) : 10 3M Avg. daily vol (nos) : 5,216,686 Shares o/s (mn) : 259 Financial Summary Consolidated* Y/E Mar

More information

Market Strategy. September 2012 Private Client Research

Market Strategy. September 2012 Private Client Research Market Strategy September 2012 Private Client Research Index The fall and rise of the market Current scenario / valuations Our take Sectors / Stocks Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11

More information

Economy News. Corporate News AUGUST 26, 2016

Economy News. Corporate News AUGUST 26, 2016 AUGUST 26, 2016 Economy News The government is set to seek formal Cabinet approval for shutting down seven state-owned companies, with their respective line ministries apparently agreed. This would be

More information

ATTRACTIVE. Banks. India

ATTRACTIVE. Banks. India Banks India ATTRACTIVE JUNE 12, 18 UPDATE BSE30: 35,483 Checks and balances on working capital. RBI has issued a draft guideline that aims to improve credit discipline among large borrowers (`1.5 bn) on

More information

Source: Company, Kotak Securities Private Client Research

Source: Company, Kotak Securities Private Client Research Company Update Stock Details Market cap (Rs mn) : 28750 52-wk Hi/Lo (Rs) : 750 / 460 Face Value (Rs) : 2 3M Avg. daily volume (mn) : 204,605 Shares o/s (m) : 55 Source: Bloomberg Financial Summary Y/E

More information

News Highlights. What s Inside

News Highlights. What s Inside Morning Insight OCTOBER 9, 2018 % Chg 8-Oct 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 34,474 0.3 (10.2) (3.3) NIFTY Index 10,348 0.3 (10.7) (3.9) NSEBANK Index 24,618 0.7 (10.4) (7.1) NIFTY 500 Index

More information

News Highlights. What s Inside. Result Update: Time Technoplast Ltd

News Highlights. What s Inside. Result Update: Time Technoplast Ltd Morning Insight NOVEMBER 22, 2018 % Chg 21-Nov 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 35,200 (0.8) 2.6 (8.1) NIFTY Index 10,600 (0.5) 2.9 (8.4) NSEBANK Index 26,262 0.6 4.7 (7.1) NIFTY 500 Index

More information

BHARAT ELECTRONICS LTD (BEL)

BHARAT ELECTRONICS LTD (BEL) Company Update Stock Details Market cap (Rs mn) : 196389 52-wk Hi/Lo (Rs) : 193 / 74 Face Value (Rs) : 1 3M Avg. daily vol (Nos) : 13,666,090 Shares o/s (mn) : 2437 Source: Bloomberg Financial Summary

More information

BANDHAN BANK LTD (BDL)

BANDHAN BANK LTD (BDL) IPO NOTE Nipun Gupta nipun.gupta@kotak.com +91 22 6218 6433 BANDHAN BANK LTD (BDL) BACKGROUND PRIVATE CLIENT RESEARCH MARCH 13, 2018 NOT RATED Bandhan Bank Ltd is a commercial bank focused on serving under

More information

WONDERLA HOLIDAYS LIMITED

WONDERLA HOLIDAYS LIMITED Company Update Stock Details Market cap (Rs mn) : 15255 52-wk Hi/Lo (Rs) : 425 / 259 Face Value (Rs) : 10 3M Avg. daily vol (Nos) : 32,201 Shares o/s (mn) : 57 Source: Bloomberg Financial Summary - Standalone

More information

News Highlights. What s Inside. Company Update: Finolex Industries Ltd

News Highlights. What s Inside. Company Update: Finolex Industries Ltd Morning Insight % Chg 22-Nov 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 34,981 (0.6) 2.5 (8.6) NIFTY Index 10,527 (0.7) 2.7 (9.0) NSEBANK Index 25,999 (1.0) 3.7 (8.0) NIFTY 500 Index 8,879 (0.7) 3.5

More information

Bajaj Allianz reported a 20% decline in individual APE on the high chunk of business (up 350% in April 2017) booked in FY2017.

Bajaj Allianz reported a 20% decline in individual APE on the high chunk of business (up 350% in April 2017) booked in FY2017. Insurance MAY 13, 2018 UPDATE BSE-30: 35,536 Down, from a high base. Private life insurance companies reported a 2% decline in individual APE in April 2018 on a high base (86% in April 2017). This was

More information

BUY. Suprajit Engineering (SEL) Automobiles

BUY. Suprajit Engineering (SEL) Automobiles Suprajit Engineering (SEL) Automobiles Strong performance. Suprajit Engineering reported a consolidated net profit of `210 mn in 3QFY16, which was 2% higher than our estimates. Phoenix Lamps was consolidated

More information

STOCK RECOMMENDATIONS

STOCK RECOMMENDATIONS STOCK RECOMMENDATIONS PRIVATE CLIENT RESEARCH MARCH 21, 2017 Agri-Products Insecticides (India) Ltd ACCUMULATE 555 577 621 11.9 09-Feb-17 11,463 28.2 38.8 19.7 14.3 13.4 16.2 11.7 9.2 Finolex Industries

More information

Economy News. Corporate News SEPTEMBER 15, 2015

Economy News. Corporate News SEPTEMBER 15, 2015 SEPTEMBER 15, 2015 Economy News Inflation based on the wholesale price index (WPI) decelerated for the tenth consecutive month, and was -4.95 per cent in August compared with -4.05 per cent in July. At

More information

News Highlights. What s Inside

News Highlights. What s Inside Morning Insight OCTOBER 30, 2018 % Chg 29-Oct 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 34,067 2.2 (6.0) (8.8) NIFTY Index 10,251 2.2 (6.2) (9.1) NSEBANK Index 24,960 2.2 (0.6) (9.7) NIFTY 500 Index

More information

News Highlights. What s Inside. Company Update: NMDC Ltd

News Highlights. What s Inside. Company Update: NMDC Ltd Morning Insight % Chg 2-Aug 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 3,97 0.5 4.2 10.6 NIFTY Index 11,739 0.4 4.1 9. NSEBANK Index 2,270 0.0 2.3 6.2 NIFTY 500 Index 9,96 0.3 4.2 7.3 CNXMcap Index

More information

Economy News. Corporate News NOVEMBER 22, 2016

Economy News. Corporate News NOVEMBER 22, 2016 NOVEMBER 22, 2016 Economy News People have exchanged and deposited over Rs 5.44 trillion worth of scrapped Rs 500/1,000 notes at different banks till November 18 following demonetisation of the higher

More information

Stock Recommendations

Stock Recommendations UST 2, 2017 Name of the Company Latest Price Price as Latest Upside/ Latest Mkt Reco^ as on on latest Price (Down- Report Cap EPS (Rs) EPS gth (%) PE (x) RoE (%) EV/EBITDA (x) 28-Jan Report target^ side)

More information

EVEREADY INDUSTRIES INDIA LIMITED (EIIL)

EVEREADY INDUSTRIES INDIA LIMITED (EIIL) Company Update Stock Details Market cap (Rs mn) : 13763 52-wk Hi/Lo (Rs) : 465 / 175 Face Value (Rs) : 5 3M Avg. daily vol (Nos) : 162,827 Shares o/s (mn) : 72.7 Source: Bloomberg Financial Summary Y/E

More information

News Highlights. What s Inside

News Highlights. What s Inside Morning Insight AUGUST 28, 2018 % Chg 27-Aug 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 38,694 1.2 3.6 10.8 NIFTY Index 11,692 1.2 3.7 10.2 NSEBANK Index 28,264 1.5 2.3 7.6 NIFTY 500 Index 9,959 1.1

More information

MIRC ELECTRONICS LTD PRIVATE CLIENT RESEARCH INITIATING COVERAGE JANUARY 23, 2018

MIRC ELECTRONICS LTD PRIVATE CLIENT RESEARCH INITIATING COVERAGE JANUARY 23, 2018 PRIVATE CLIENT RESEARCH JANUARY 23, 2018 Sanjeev Zarbade sanjeev.zarbade@kotak.com +91 22 6218 6424 Stock details BSE code : 500279 Market cap (Rs mn) : 11660.5 Free float (%) : 42% 52-wk Hi/Lo (Rs) :

More information

HINDUSTAN ZINC LTD PRICE RS.284 TARGET RS.300 ACCUMULATE. Company Update. Key Highlights. Outlook

HINDUSTAN ZINC LTD PRICE RS.284 TARGET RS.300 ACCUMULATE. Company Update. Key Highlights. Outlook Company Update Stock Details Market cap (Rs mn) : 1201681 52-wk Hi/Lo (Rs) : 340 / 261 Face Value (Rs) : 2 3M Avg. daily vol (Nos) : 1,882,902 Shares o/s (mn) : 4225 Source: Bloomberg Financial Summary

More information

News Highlights. What s Inside. Result Update: AksharChem (India) Ltd

News Highlights. What s Inside. Result Update: AksharChem (India) Ltd Morning Insight % Chg 21-Feb 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 35,898 0.4 (1.9) 2.0 NIFTY Index 10,790 0.5 (1.6) 1.8 NSEBANK Index 27,052 0.4 (1.7) 3.0 NIFTY 500 Index 8,902 0.6 (2.8) (0.4)

More information

NEUTRAL. Automobiles. India

NEUTRAL. Automobiles. India Automobiles India NEUTRAL FEBRUARY 01, 2017 UPDATE BSE-30: 28,142 PV and CV recover in January 2017. Passenger vehicle volumes recovered sharply in January 2017 and we reckon industry likely grew by double

More information

COCHIN SHIPYARD LTD (COSH)

COCHIN SHIPYARD LTD (COSH) Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Stock details BSE code : 540678 NSE code : COCHINSHIP Market cap (Rs bn) : 77.0 Free float (%) : 25.0 52 wk Hi/Lo (Rs) : 586/ 435 Avg daily volume :

More information

Market Watch MORNING BRIEFS. 6 th,december,2017 MARKET BREADTH: 10, %

Market Watch MORNING BRIEFS. 6 th,december,2017 MARKET BREADTH: 10, % Market Watch 6 th,december,2017 MORNING BRIEFS GLOBAL INDICES MARKET BREADTH: LTP CHANGE(PT S) CHANGE (%) DOW JONES 22,980.00 70 0.31 NASDAQ 6,762.21-13.16-0.19 S&P 500 2,554.00 3 0.12 FTSE 100 7,327.50-11.47-0.16

More information

Stock Recommendations

Stock Recommendations UST 2, 2017 Auto & Auto Ancillary Apollo Tyres ACCUMULATE 242 286 301 24.6 03-Aug-18 138,195 17.6 25.1 13.7 9.6 9.9 12.8 8.4 6.7 Ashok Leyland BUY 131 111 128 (2.5) 19-Jul-18 373,538 6.4 7.1 20.5 18.5

More information

Stock Recommendations

Stock Recommendations UST 2, 2017 SEPTEMBER 18, 2018 Auto & Auto Ancillary Apollo Tyres ACCUMULATE 239 286 301 26.0 03-Aug-18 136,622 17.6 25.1 13.6 9.5 9.9 12.8 8.3 6.7 Ashok Leyland BUY 126 111 128 1.3 19-Jul-18 359,734 6.4

More information

ATTRACTIVE. Banks. India

ATTRACTIVE. Banks. India Banks India ATTRACTIVE JUNE 12, 2017 UPDATE BSE-30: 31,262 Maharashtra announces farm loan waiver. After UP and Punjab, Maharashtra becomes the latest state to announce farm loan waiver. While exact criteria

More information

VIP INDUSTRIES LTD (VIP)

VIP INDUSTRIES LTD (VIP) PRIVATE CLIENT RESEARCH SEPTEMBER 21, 2017 Amit Agarwal agarwal.amit@kotak.com +91 22 6218 6439 Stock details BSE code : 507880 NSE code : VIPIND Market cap (Rs bn) : 35.7 Free float (%) : 47.5 52 wk Hi/Lo

More information

News Highlights. What s Inside

News Highlights. What s Inside Morning Insight OCTOBER 16, 2018 % Chg 15-Oct 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 34,865 0.4 (8.5) (4.6) NIFTY Index 10,513 0.4 (8.7) (4.6) NSEBANK Index 25,388 (0.0) (6.5) (5.7) NIFTY 500 Index

More information

Economy News. Corporate News AUGUST 21, 2015

Economy News. Corporate News AUGUST 21, 2015 AUGUST 21, 2015 Economy News Reserve Bank of India Governor indicated that policy measures may be warranted to counter any long-term plan by the Chinese to push the yuan down to gain an edge on exports.

More information

News Highlights. What s Inside. Company Update: Radico Khaitan Ltd

News Highlights. What s Inside. Company Update: Radico Khaitan Ltd Morning Insight % Chg 22-Feb 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 35,871 (0.1) (1.6) 2.5 NIFTY Index 10,792 0.0 (1.2) 2.5 NSEBANK Index 26,868 (0.7) (2.2) 3.3 NIFTY 500 Index 8,920 0.2 (2.3)

More information

News Highlights. What s Inside. Company Update: Time Technoplast Ltd

News Highlights. What s Inside. Company Update: Time Technoplast Ltd Morning Insight % Chg 15-Mar 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 38,024 0.7 6.2 5.7 NIFTY Index 11,427 0.7 6.6 5.8 NSEBANK Index 29,381 1.6 9.7 9.5 NIFTY 500 Index 9,499 0.6 7.6 4.5 CNXMcap

More information